Abstract 4640: Randomized, phase 1 crossover study assessing the bioequivalence of tablet and capsule formulations of dovitinib (TKI258)

John Sarantopoulos; Sanjay Goel; Vincent Chung; Pamela Munster; Shubham Pant; Manish Patel; Jeffrey Infante; Hussein Tawbi; Carlos Becerra; Justine Bruce; Fairooz Kabbinavar; Howard Kaufman; A. Craig Lockhart; Eugene Tan; Shu Yang; Mariama Diallo; Jeffrey Scott; Sunil Sharma

doi:10.1158/1538-7445.AM2014-4640

Back

Abstract 4640: Randomized, phase 1 crossover study assessing the bioequivalence of tablet and capsule formulations of dovitinib (TKI258)

Journal article

Peer reviewed

Abstract 4640: Randomized, phase 1 crossover study assessing the bioequivalence of tablet and capsule formulations of dovitinib (TKI258)

John Sarantopoulos, Sanjay Goel, Vincent Chung, Pamela Munster, Shubham Pant, Manish Patel, Jeffrey Infante, Hussein Tawbi, Carlos Becerra, Justine Bruce, …

Cancer research (Chicago, Ill.), Vol.74(19 Supplement), pp.4640-4640

2014-10-01

DOI: https://doi.org/10.1158/1538-7445.AM2014-4640

Metrics

2 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Abstract 4640: Randomized, phase 1 crossover study assessing the bioequivalence of tablet and capsule formulations of dovitinib (TKI258)
Creators: John Sarantopoulos
Sanjay Goel
Vincent Chung
Pamela Munster
Shubham Pant
Manish Patel
Jeffrey Infante
Hussein Tawbi
Carlos Becerra
Justine Bruce
Fairooz Kabbinavar
Howard Kaufman
A. Craig Lockhart
Eugene Tan
Shu Yang
Mariama Diallo
Jeffrey Scott
Sunil Sharma
Publication Details: Cancer research (Chicago, Ill.), Vol.74(19 Supplement), pp.4640-4640
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031599521002976